+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Treatment of CS IA to IIIB non-bulky Hodgkins disease with 3 cycles of chemotherapy followed by high dose irradiation Results of the goelams H90-NM multicenter randomized trial



Treatment of CS IA to IIIB non-bulky Hodgkins disease with 3 cycles of chemotherapy followed by high dose irradiation Results of the goelams H90-NM multicenter randomized trial



Blood 94(10 SUPPL 1 PART 1): 386a, Nov 15




(PDF emailed within 1 workday: $29.90)

Accession: 035980360

Download citation: RISBibTeXText


Related references

Bulky Hodgkins disease Treatment with an initial 7-drug chemotherapy delivered over 12 weeks followed by high-dose Extended Field irradiation Seven-year results of the GOELAMS H90M multicentric randomized trial. Blood 94(10 SUPPL 1 PART 1): 528a, Nov 15, 1999

High-risk Hodgkins disease ABVD chemotherapy followed by beam-conditioned autologous stem cell transplantation and focal radiotherapy versus intensive chemotherapy followed by involved field RT Two-year results of the Goelams H97-GM multicentric randomized trial. Blood 96(11 Part 1): 791a, November 16, 2000

Very High Risk Hodgkins Disease ABVD Plus BEAM Followed by Autologous Stem Cell Transplantation and Radiotherapy Versus Intensive Chemotherapy and RT Interim Results of the GOELAMS H97-GM Multicentric Randomized Trial. Blood 100(11): Abstract No 811, November 16, 2002

Early versus late intensification for patients with high-risk Hodgkin lymphoma-3 cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell transplantation: five-year results of a randomized trial on behalf of the GOELAMS Group. Cancer 113(12): 3323-3330, 2008

Treatment of patients with advanced or bulky Hodgkin disease with a 12-week doxorubicin, bleomycin, vinblastine, and dacarbazine-like chemotherapy regimen followed by extended-field, full-dose radiotherapy: long-term results of the Groupe Ouest et Est des Leucémies et Autres Maladies de Sang H90-A/B Multicenter Randomized Trial. Cancer 95(10): 2169-2179, 2002

Frontline High-Dose Chemotherapy with Autologous Stem Cell Transplantation vs Standard CHOP Regimen for Patients with Non IPI High-Risk Intermediate or High-Grade Lymphomas Final Results of a Randomized Trial by the GOELAMS. Blood 100(11): Abstract No 675, November 16, 2002

HD-RI First results of a randomized trial comparing aggressive chemotherapy with high-dose therapy and hematopoietic stem cell transplantation in patients with chemosensitive relapse of Hodgkins disease. Blood 90(10 SUPPL 1 PART 1): 115A, Nov 15, 1997

High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years. Blood 113(5): 995-1001, 2008

Three cycles of MOPP/ABV hybrid and involved-field irradiation is more effective than subtotal nodal irradiation in favorable supradiaphragmatic clinical stages I-II Hodgkins disease Prelimi-nary results of the EORTC-GELA H8-F randomized trial in 543 patients. Blood 96(11 Part 1): 575a, November 16, 2000

High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trial. Bone Marrow Transplantation 33(4): 381-388, 2003

Reduced combined modality treatment for Hodgkins disease results of a randomized multicenter trial. Annals of Hematology 73(SUPPL 2): A150, 1996

Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkins and aggressive non-Hodgkins lymphoma Results of a multicenter phase-II study. Blood 98(11 Part 1): 681a, November 16, 2001

Interim analysis of a multicenter phase-II trial using high-dose sequential chemotherapy and autologous stem cell support for relapsed or refractory Hodgkins and non-Hodgkins lymphoma. Annals of Hematology 77(SUPPL 2): S214, 1998

Chemotherapy vs radiotherapy for remission consolidation after three double cycles of cyclophosphamide vincristine procarbazine prednisone copp and doxorubicin bleomycin vinblastine dacarbazine abvd a randomized trial in patients with stages iiib iv hodgkins lymphoma. Journal of Cancer Research & Clinical Oncology 116(SUPPL PART 1): 613, 1990

High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by GOELAMS. Blood 105(10): 3817-3823, 2005